CD8A and neoplasm: Our above findings that alum-CpG-HH2-NY vaccine was able to enhance humoral immunity, induce NK cell activity and activate CTLs activity suggest that CD4+ T, NK and CD8+ T cells may play an important role in anti-tumor immunity.